Imperial College Healthcare

London W2 1NY

2 studies enrolling now · 6 studies all time

What they study most

Advanced or Metastatic Non-small Cell Lung Cancer, Atherosclerosis, Multiple Myeloma, Percutaneous Coronary Intervention, Staphylococcus Aureus Bacteremia, Traumatic Injury

Studies at this site

• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
• Staphylococcus Aureus Network Adaptive Platform Trial — Recruiting now
• A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer — Running, not enrolling
• Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment — Running, not enrolling
• Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study ) — Stopped early
• IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact — Running, not enrolling